HR+, HER2-, Advanced Breast Cancer (DBCOND0140304)
Identifiers
- Synonyms
- HR+HER2- Advanced Breast Cancer / HR+/HER2- Advanced Breast Cancer / Advanced HR + HER2 - breast cancer
Associated Data
- Indicated Drugs and Targets
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT06625333 A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation No drug interventions Not Available Not Available not_yet_recruiting NCT06148506 A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia No drug interventions Not Available Not Available recruiting NCT05983107 Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer treatment 2 recruiting NCT05586841 Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study treatment 1 not_yet_recruiting NCT06556862 Exploration of Dalpiciclib + Tucidinostat in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor treatment 2 not_yet_recruiting NCT04473040 Managed Access Program to Provide Access to Alpelisib for Patients With Advanced Breast Cancer Not Available Not Available available